idarubicin has been researched along with epirubicin in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (29.63) | 18.7374 |
| 1990's | 10 (18.52) | 18.2507 |
| 2000's | 17 (31.48) | 29.6817 |
| 2010's | 6 (11.11) | 24.3611 |
| 2020's | 5 (9.26) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ames, MM; Kuffel, MJ; Reid, JM | 1 |
| Brown, TD; Burris, HA; Havlin, KA; O'Rourke, TJ; Rodriguez, GI; Wall, JG; Weiss, GR | 1 |
| Green, MD; Muggia, FM | 1 |
| Cairo, MS; Sender, L; Toy, C; van de Ven, C | 1 |
| Arteaga, CL; Brown, TD; Craig, JB; Harman, GS; Havlin, KA; Koeller, JM; Kuhn, JG; Von Hoff, DD; Weiss, GR | 1 |
| Capalbo, MI; Stipani, I; Zara, V | 1 |
| Grankvist, K; Henriksson, R; Stendahl, U | 1 |
| Chen, ZM; Colombo, T; Conforti, L; Fiedorowicz, RJ; Grazia Donelli, M; Latini, R; Marchi, S; Paolini, A; Riva, E; Zuanetti, G | 1 |
| Raymond, V; Young, CW | 1 |
| Clagett-Carr, K; Leyland-Jones, B; Russo, M; Sarosy, G; Weiss, RB | 1 |
| Falkson, G; Iturralde, MP; Vorobiof, DA | 1 |
| Airiau, J; Bégué, JM; Guillouzo, A; Kernaleguen, D; Le Bot, MA; Ratanasavanh, D; Riché, C; Robert, J | 1 |
| Robert, J | 1 |
| Bonadonna, G; Bonfante, V; Brambilla, C; Crippa, F; Ferrari, L; Rossi, A; Valagussa, P; Villani, F | 1 |
| Berens, ME; Modest, EJ; Saito, T; Welander, CE | 1 |
| Ganzina, F; Hurteloup, P | 1 |
| Arcamone, F | 2 |
| Ogawa, M | 1 |
| Arcamone, F; Menozzi, M; Valentini, L; Vannini, E | 1 |
| Di Simone, D; Grassi, B; Malvaldi, G; Mattii, L; Petrini, M; Testi, R; Zaccaro, L | 1 |
| Alken, P; Köhrmann, KU; Kreukler, C; Siegsmund, MJ; Stendler, A | 1 |
| Avilés, A; Díaz Maqueo, JC; Garcia, EL; Huerta-Guzman, J; Nambo, MJ; Talavera, A | 1 |
| Avanzini, P; Baldini, L; Brugiatelli, M; Carotenuto, M; Clò, V; Di Renzo, N; Dini, D; Federico, M; Gobbi, PG; Lombardo, M; Silingardi, V; Vallisa, D | 1 |
| Barbara, C; Bocci, G; Danesi, R; Del Tacca, M; Di Paolo, A; Fogli, S; Innocenti, F | 1 |
| Andersson, BS; Carlberg, M; Eksborg, S; Sundberg, M; Vidal, RF | 1 |
| Lankelma, J; Westerhoff, HV; Wielinga, PR | 1 |
| Aita, P; Bearz, A; Boiocchi, M; Colussi, AM; Corona, G; Crivellari, D; Robieux, I; Sorio, R; Stocco, F; Toffoli, G | 1 |
| Gatto, B; Moro, S; Palumbo, M; Sissi, C; Zagotto, G | 1 |
| Conte, P; Danesi, R; Del Tacca, M; Fogli, S; Gennari, A | 1 |
| Bengala, C; Biadi, O; Conte, PF; Danesi, R; Del Tacca, M; Donati, S; Favre, C; Fogli, S; Guarneri, V; Innocenti, F; Mariani, M; Pazzagli, I | 1 |
| McHowat, J; Sarvazyan, N; Swift, L | 1 |
| Gentilini, O; Goldhirsch, A; Martinelli, G; Peccatori, F | 1 |
| Miura, T; Muraoka, S | 1 |
| Seiter, K | 1 |
| Baldini, L; Brugiatelli, M; Di Renzo, N; Federico, M; Gobbi, PG; Lombardo, M; Luminari, S; Mammi, C; Merli, F; Montanini, A; Partesotti, G; Polimeno, G; Sacchi, S; Stelitano, C | 1 |
| Lambert, WE; Maudens, KE; Wille, SM | 1 |
| Bárdi, E; Bobok, I; Kappelmayer, J; Kiss, C; V Oláh, A | 1 |
| Beske, F; Boos, J; Dantonello, T; Gadner, H; Hallmen, E; Int-Veen, C; Kazanowska, B; Klingebiel, T; Koscielniak, E; Marky, I; Treuner, J | 1 |
| Bhartia, S; Proctor, SJ; Sieniawski, M; Wilkinson, J | 1 |
| Barba, G; Cicconi, L; Divona, M; Falini, B; Hasan, SK; Lo-Coco, F; Mecucci, C; Metzler, M; Ottone, T | 1 |
| Johari-Ahar, M; Kian, R; Seyed Ahmadian, SM; Zakerhamidi, MS | 1 |
| Abergel, A; Aho, S; Boulin, M; Boyer, L; Chabrot, P; Fagnoni, P; Guiu, B; Hillon, P; Sautou, V; Tavernier, J; Vadot, L | 1 |
| Bhatnagar, R; Dahiya, P; Gl, B; Grover, A; Gupta, M; Rajput, R; Thakur, JK | 1 |
| Daniels, RL; Phelps, MC; Tavener, AM | 1 |
| Bonnabry, P; Fleury-Souverain, S; Guillarme, D; Maurin, J; Rudaz, S | 1 |
| Bai, R; Chang, X; Li, L; Li, Y; Lin, R; Liu, N; Liu, X; Peng, X; Ruan, Y; Tang, R; Wang, X; Wen, S | 1 |
| Huang, M; Li, M; Wang, H; Xiang, Z; Yan, H; Zhao, C | 1 |
13 review(s) available for idarubicin and epirubicin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New anticancer agents.
Topics: Alkaloids; Animals; Antineoplastic Agents; Azacitidine; Biphenyl Compounds; Chrysenes; Deoxycytidine; Echinomycin; Epirubicin; Etanidazole; Flavonoids; Gemcitabine; Guanidines; Humans; Idarubicin; Menogaril; Mitoguazone; Neoplasms; Nitroimidazoles; Nogalamycin; Organoplatinum Compounds; Paclitaxel; Pentostatin; Polymers; Propylene Glycols; Ribavirin; Sulfonylurea Compounds; Trimetrexate; Vidarabine Phosphate | 1991 |
New anthracycline antitumor antibiotics.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Cardiomyopathies; Carubicin; Doxorubicin; Drug Resistance; Epirubicin; Humans; Idarubicin; Menogaril; Molecular Structure; Neoplasms; Nogalamycin | 1991 |
New anticancer agents.
Topics: Adenine; Antibiotics, Antineoplastic; Antineoplastic Agents; Biphenyl Compounds; Depsipeptides; Echinomycin; Epirubicin; Flavonoids; Guanidines; Humans; Idarubicin; Imides; Isoquinolines; Menogaril; Naphthalimides; Nogalamycin; Organophosphonates; Pentostatin; Peptides, Cyclic; Polymers; Vidarabine Phosphate | 1988 |
Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Topics: Aclarubicin; Anthraquinones; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Cell Survival; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Heart; Humans; Idarubicin; Leukemia; Menogaril; Mitoxantrone; Naphthacenes; Nogalamycin; Sarcoma; Structure-Activity Relationship | 1986 |
Anthracycline analogs: the past, present, and future.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Epirubicin; Female; Guinea Pigs; Heart; Humans; Idarubicin; Male; Menogaril; Mice; Nogalamycin; Rabbits; Rats | 1986 |
[Pharmacokinetics of new anthracyclines].
Topics: Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Epirubicin; Humans; Idarubicin | 1988 |
Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicin.
Topics: Antibiotics, Antineoplastic; Bone Marrow; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Heart; Humans; Idarubicin; Neoplasms | 1986 |
[Current status of clinical results of new antitumor drugs].
Topics: Aminoacridines; Amsacrine; Anthracyclines; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Aziridines; Benzoquinones; Carboplatin; Carubicin; Cisplatin; Daunorubicin; Doxorubicin; Eflornithine; Epirubicin; Humans; Idarubicin; Mitoxantrone; Naphthacenes; Neoplasms; Organoplatinum Compounds; Ornithine; Ribavirin | 1985 |
Anthracyclines: recent developments in their separation and quantitation.
Topics: Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Daunorubicin; Doxorubicin; Electrophoresis, Capillary; Epirubicin; Idarubicin; Spectrophotometry, Ultraviolet | 2001 |
Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Area Under Curve; Doxorubicin; Epirubicin; Half-Life; Humans; Idarubicin; Metabolic Clearance Rate; Neoplasms; Prodrugs; Structure-Activity Relationship | 2002 |
Toxicity of the topoisomerase II inhibitors.
Topics: Antineoplastic Agents; Cardiovascular Diseases; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Epirubicin; Etoposide; Humans; Idarubicin; Leukemia; Middle Aged; Mitoxantrone; Mucositis; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors; Vascular Diseases | 2005 |
The Role of Mitochondrial Quality Control in Anthracycline-Induced Cardiotoxicity: From Bench to Bedside.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Calcium; Cardiotoxicity; Daunorubicin; Doxorubicin; Epirubicin; Humans; Idarubicin; Mitochondria; Mitochondrial Proteins; Myocytes, Cardiac; Reactive Oxygen Species | 2022 |
9 trial(s) available for idarubicin and epirubicin
| Article | Year |
|---|---|
New anthracycline antitumor antibiotics.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Cardiomyopathies; Carubicin; Doxorubicin; Drug Resistance; Epirubicin; Humans; Idarubicin; Menogaril; Molecular Structure; Neoplasms; Nogalamycin | 1991 |
Anthracycline analogs: the past, present, and future.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Epirubicin; Female; Guinea Pigs; Heart; Humans; Idarubicin; Male; Menogaril; Mice; Nogalamycin; Rabbits; Rats | 1986 |
Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicin.
Topics: Antibiotics, Antineoplastic; Bone Marrow; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Heart; Humans; Idarubicin; Neoplasms | 1986 |
Epirubicin (CEOP-Bleo) versus idaurubicin (CIOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkin's lymphoma: dose escalation studies.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1997 |
Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Heart Diseases; Hematologic Diseases; Humans; Idarubicin; Italy; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proportional Hazards Models; Remission Induction; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma.
Topics: Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Daunorubicin; Doxorubicin; Drug Monitoring; Epirubicin; Humans; Idarubicin; Linear Models; Molecular Structure; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 1999 |
Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients.
Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Cyclophosphamide; Daunorubicin; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Idarubicin; Maximum Tolerated Dose; Methotrexate; Middle Aged; Neoplasm Metastasis; Paclitaxel; Taxoids; Time Factors | 2000 |
The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 study.
Topics: Anthracyclines; Epirubicin; Glucuronates; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Prognosis; Remission Induction; Survival Analysis; Time Factors; Treatment Outcome | 2006 |
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Thiotepa; Treatment Outcome; Vincristine | 2008 |
35 other study(ies) available for idarubicin and epirubicin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture.
Topics: Antibiotics, Antineoplastic; Cell Division; Daunorubicin; DNA Damage; DNA, Neoplasm; Doxorubicin; Epirubicin; Glioma; Humans; Idarubicin; Leukemia, Myeloid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1992 |
Effect of idarubicin and epirubicin on in vitro polymorphonuclear function: diminished superoxide radical formation compared to their parent compounds daunorubicin and doxorubicin.
Topics: Cyclosporins; Daunorubicin; Doxorubicin; Epirubicin; Free Radicals; Humans; Idarubicin; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Protein Kinase C; Superoxides; Verapamil | 1990 |
Effect of anthracycline antibiotics on the reconstituted mitochondrial tricarboxylate carrier.
Topics: Animals; Antibiotics, Antineoplastic; Carrier Proteins; Citrates; Daunorubicin; Doxorubicin; Epirubicin; Idarubicin; Kinetics; Mitochondria, Liver; Rats | 1989 |
Comparative study of demethoxydaunorubicin with other anthracyclines on generation of oxygen radicals and clonogenic survival of fibroblasts.
Topics: Animals; Antibiotics, Antineoplastic; Catalase; Cell Line; Cell Survival; Chelating Agents; Clone Cells; Cricetinae; Daunorubicin; Doxorubicin; Electrodes; Epirubicin; Fibroblasts; Free Radicals; Idarubicin; Oxygen; Superoxide Dismutase | 1989 |
Effects of three new anthracyclines and doxorubicin on the rat isolated heart.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Epirubicin; Heart; Idarubicin; Male; Myocardial Contraction; Myocardium; Rats; Rats, Inbred Strains | 1987 |
Radionuclide angiographic monitoring in patients treated with potentially cardiotoxic cytostatic drugs.
Topics: Amsacrine; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Electrocardiography; Epirubicin; Female; Heart; Humans; Idarubicin; Male; Mitoxantrone; Prospective Studies; Radionuclide Angiography; Stroke Volume | 1988 |
Different cytotoxicity and metabolism of doxorubicin, daunorubicin, epirubicin, esorubicin and idarubicin in cultured human and rat hepatocytes.
Topics: Adolescent; Adult; Animals; Cells, Cultured; Daunorubicin; Doxorubicin; Epirubicin; Epithelium; Humans; Idarubicin; L-Lactate Dehydrogenase; Liver; Male; Rats; Rats, Inbred Strains; Species Specificity | 1988 |
New anthracycline analogs in advanced breast cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Idarubicin; Middle Aged; Naphthacenes | 1986 |
Antitumor activity of new anthracycline analogues in combination with interferon alfa.
Topics: Cell Line; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Drug Synergism; Epirubicin; Female; Humans; Idarubicin; Interferon Type I; Tumor Stem Cell Assay | 1987 |
Properties of antitumor anthracyclines and new developments in their application: Cain memorial award lecture.
Topics: Antibiotics, Antineoplastic; Cell Survival; Daunorubicin; Doxorubicin; Epirubicin; Humans; Idarubicin; Kinetics; Metabolic Clearance Rate; Naphthacenes; Solubility; Structure-Activity Relationship; Tissue Distribution | 1985 |
[Adriamycin and its analogs].
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Chemical Phenomena; Chemistry; Daunorubicin; DNA, Neoplasm; Doxorubicin; Epirubicin; Humans; Idarubicin; Stereoisomerism | 1984 |
Self-association of doxorubicin and related compounds in aqueous solution.
Topics: Chemistry, Pharmaceutical; Daunorubicin; Doxorubicin; Epirubicin; Idarubicin; Solutions; Spectrophotometry | 1984 |
Evaluation of resistance index of several anticancer agents on parental and resistant P-388 cell lines.
Topics: Animals; Biological Transport; DNA Replication; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Idarubicin; In Vitro Techniques; Leukemia P388; Mice; Mitoxantrone; Tumor Cells, Cultured; Verapamil | 1995 |
Enhanced in vitro cytotoxicity of idarubicin compared to epirubicin and doxorubicin in rat prostate carcinoma cells.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Cell Division; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Humans; Idarubicin; KB Cells; Lethal Dose 50; Male; Prostatic Neoplasms; Rats; Tumor Cells, Cultured | 1997 |
Anthraquinone-induced cell injury: acute toxicity of carminomycin, epirubicin, idarubicin and mitoxantrone in isolated cardiomyocytes.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Carubicin; Cell Size; Cell Survival; Epirubicin; Idarubicin; Inhibitory Concentration 50; Male; Mitoxantrone; Myocardium; Oxygen Consumption; Rats; Rats, Sprague-Dawley | 1999 |
The relative importance of passive and P-glycoprotein mediated anthracycline efflux from multidrug-resistant cells.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Biological Transport, Active; Cell Compartmentation; Cell Line; Cell Membrane Permeability; Daunorubicin; Digitonin; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Humans; Idarubicin; Kinetics; Verapamil | 2000 |
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Daunorubicin; Deoxycytidine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Idarubicin; Melphalan; Middle Aged; Neoplasm Metastasis; Paclitaxel; Remission Induction; Taxoids; Thiotepa; Time Factors; Transplantation Conditioning; Treatment Outcome | 2003 |
Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity.
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Cardiomyopathies; Cells, Cultured; Daunorubicin; Doxorubicin; Epirubicin; Group VI Phospholipases A2; Heart Ventricles; Idarubicin; Myocytes, Cardiac; Oxidative Stress; Phospholipases A; Phospholipases A2; Rats; Rats, Sprague-Dawley | 2003 |
Chemotherapy during pregnancy: what is really safe?
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Fetal Diseases; Humans; Idarubicin; Maternal Exposure; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Treatment Outcome | 2004 |
Thiol oxidation induced by oxidative action of adriamycin.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Benzoquinones; Creatine Kinase; Daunorubicin; Doxorubicin; Electron Spin Resonance Spectroscopy; Epirubicin; Free Radicals; Glutathione; Horseradish Peroxidase; Hydrogen Peroxide; Hypoxanthine; Idarubicin; Oxidation-Reduction; Sulfhydryl Compounds; Xanthine Oxidase | 2004 |
Traces of phosgene in chloroform: consequences for extraction of anthracyclines.
Topics: Amines; Anthracyclines; Chloroform; Chromatography, Liquid; Daunorubicin; Doxorubicin; Epirubicin; Ethanol; Idarubicin; Molecular Structure; Phosgene; Reproducibility of Results; Solvents; Spectrometry, Fluorescence | 2007 |
Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer.
Topics: Acetylglucosaminidase; Adolescent; Adult; Albuminuria; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Child; Child, Preschool; Creatinine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Idarubicin; Infant; Kidney Diseases; Kidney Tubules, Proximal; Lymphoma, Non-Hodgkin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Retrospective Studies | 2007 |
Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone--rituximab
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Incidence; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisolone; Prognosis; Registries; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine | 2009 |
Clustering of genomic breakpoints at the MLL locus in therapy-related acute leukemia with t(4;11)(q21;q23).
Topics: Antibiotics, Antineoplastic; Base Sequence; Breast Neoplasms; Carcinoma, Ductal, Breast; Chromosome Breakpoints; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Epirubicin; Female; Genetic Loci; Humans; Idarubicin; Leukemia, Biphenotypic, Acute; Leukemia, Promyelocytic, Acute; Middle Aged; Molecular Sequence Data; Multigene Family; Topoisomerase Inhibitors; Translocation, Genetic | 2014 |
Photo-physical behavior of some antitumor anthracycline in solvent media with different polarity.
Topics: Anthracyclines; Antineoplastic Agents; Chemistry, Pharmaceutical; Coloring Agents; Doxorubicin; Epirubicin; Hydrogen Bonding; Idarubicin; Molecular Conformation; Solvents; Spectrometry, Fluorescence | 2014 |
Comparison of two transarterial chemoembolization strategies for hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Humans; Idarubicin; Infusions, Intra-Arterial; Liver Neoplasms; Male; Retrospective Studies; Treatment Outcome | 2014 |
COMMON STEM. -rubicin.
Topics: Anthracyclines; Daunorubicin; Doxorubicin; Epirubicin; Humans; Idarubicin; Terminology as Topic | 2016 |
Structure-based drug repurposing to inhibit the DNA gyrase of Mycobacterium tuberculosis.
Topics: Adenosine Triphosphatases; Antitubercular Agents; Circular Dichroism; DNA Gyrase; Doxorubicin; Drug Design; Drug Repositioning; Epirubicin; Glycosides; Idarubicin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Surface Plasmon Resonance; Topoisomerase II Inhibitors | 2020 |
Anthracycline-induced cytotoxicity in the GL261 glioma model system.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Comet Assay; Cytotoxins; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Glioma; Humans; Idarubicin; Mice; Models, Biological; Neuroglia | 2021 |
Development and application of a liquid chromatography coupled to mass spectrometry method for the simultaneous determination of 23 antineoplastic drugs at trace levels.
Topics: Antineoplastic Agents; Busulfan; Carboplatin; Chromatography, Liquid; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Fluorouracil; Ganciclovir; Humans; Idarubicin; Ifosfamide; Irinotecan; Methanol; Methotrexate; Oxaliplatin; Paclitaxel; Pemetrexed; Tandem Mass Spectrometry; Topotecan; Vinblastine; Vincristine; Water | 2022 |
Idarubicin versus epirubicin in drug-eluting beads-transarterial chemoembolization for treating hepatocellular carcinoma: A real-world retrospective study.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Humans; Idarubicin; Liver Neoplasms; Retrospective Studies; Treatment Outcome | 2023 |